[Indices of immunity and allergy in patients with viral hepatitis treated with prodigiozan].
The immune and allergic status of patients with acute viral hepatitides A and B after treatment with prodigiosan, a bacterial lipopolysaccharide preparation, was studied. The drug produced as stimulating effect on cell-mediated and humoral immunity. The development of delayed specific drug sensitization was registered in two-thirds of the patients, which correlated with the regression of clinicobiochemical manifestations of hepatitis.
Rudchik
A S
AS
Andreĭchin
M A
MA
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D003131:Combined Modality Therapy; D003289:Convalescence; D006506:Hepatitis A / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D007111:Immunity, Cellular / Q000187:drug effects; D008875:Middle Aged; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000627:therapeutic use*
D011135:Polysaccharides, Bacterial; D011354:Prodigiozan
Nekotorye pokazateli immuniteta i allergii u bol'nykh virusnymi gepatitami pri lechenii prodigiozanom.